AstraZeneca PLC (AZN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 22,369 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 7.34% | 1,771 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 55.57% | 30,189 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Dodge & Cox | Sell 100.00% | 1,261,073 | 0.09 | |
| Q4 2020 | |||||
| ≡ | Dodge & Cox | Reduce 86.13% | 7,829,100 | 0.56 | |
| Q3 2020 | |||||
| ≡ | Dodge & Cox | Reduce 19.82% | 2,246,362 | 0.21 | |
| Q2 2020 | |||||
| ≡ | Dodge & Cox | Reduce 38.84% | 7,197,938 | 0.64 | |
| Q1 2020 | |||||
| ≡ | Dodge & Cox | Reduce 26.31% | 6,617,900 | 0.58 | |
| Q4 2019 | |||||
| ≡ | Dodge & Cox | Reduce 22.92% | 7,478,200 | 0.51 | |
| Q1 2019 | |||||
| ≡ | Dodge & Cox | Reduce 0.20% | 66,400 | 0.00 | |
| Q4 2018 | |||||
| ≡ | Dodge & Cox | Reduce 2.82% | 950,000 | 0.06 | |
| Q3 2018 | |||||
| ≡ | Dodge & Cox | Reduce 2.89% | 1,000,000 | 0.05 | |
| Q2 2018 | |||||
| ≡ | Dodge & Cox | Reduce 3.14% | 1,125,000 | 0.06 | |
| Q1 2018 | |||||
| ≡ | Dodge & Cox | Reduce 4.02% | 1,500,000 | 0.08 | |
| Q3 2017 | |||||
| ≡ | Dodge & Cox | Reduce 1.07% | 400,000 | 0.02 | |
| Q1 2017 | |||||
| ≡ | Francis Chou - Chou Associates | Sell 100.00% | 13,000 | 0.23 | |
| Q3 2015 | |||||
| ≡ | Francis Chou - Chou Associates | Reduce 50.00% | 13,000 | 0.28 | |
| Q1 2009 | |||||
| ≡ | Prem Watsa - Fairfax Financial Holdings | Sell 100.00% | 25,400 | 0.01 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.